These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8797237)

  • 41. Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Psychopharmacology (Berl); 2006 Mar; 185(1):29-35. PubMed ID: 16395606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin.
    Devaud LL; Hollingsworth EB; Cooper BR
    J Neurochem; 1992 Oct; 59(4):1459-66. PubMed ID: 1402896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regulation of dopamine-D2 and serotonin-S2 receptors by chronic treatment with the serotonin-S2 antagonists, ritanserin, and setoperone.
    Leysen JE; van Gompel P; Gommeren W; Laduron PM
    Psychopharmacol Ser; 1987; 3():214-24. PubMed ID: 2950521
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of a 5-HT1A receptor agonist on striatal dopamine release.
    Bantick RA; De Vries MH; Grasby PM
    Synapse; 2005 Aug; 57(2):67-75. PubMed ID: 15906386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD; Shannon HE
    Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential attenuation of d-amphetamine-induced disruption of conditional discrimination performance by dopamine and serotonin antagonists.
    Dunn MJ; Killcross S
    Psychopharmacology (Berl); 2006 Oct; 188(2):183-92. PubMed ID: 16944104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C; Kamdar DP; Walker PD
    Synapse; 2003 Nov; 50(2):164-70. PubMed ID: 12923819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
    Kitaichi K; Yamada K; Hasegawa T; Furukawa H; Nabeshima T
    Jpn J Pharmacol; 1994 Oct; 66(2):181-9. PubMed ID: 7532732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D
    Pfeifer P; Tüscher O; Buchholz HG; Gründer G; Vernaleken I; Paulzen M; Zimmermann US; Maus S; Lieb K; Eggermann T; Fehr C; Schreckenberger M
    Addict Biol; 2017 Sep; 22(5):1449-1458. PubMed ID: 27396374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.
    Nordström AL; Farde L; Halldin C
    Psychopharmacology (Berl); 1993; 110(3):365-7. PubMed ID: 7831432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
    Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
    J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clozapine effects on glucose metabolic rate in striatum and frontal cortex.
    Potkin SG; Buchsbaum MS; Jin Y; Tang C; Telford J; Friedman G; Lottenberg S; Najafi A; Gulasekaram B; Costa J
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():63-6. PubMed ID: 7961576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
    Kehne JH; Ketteler HJ; McCloskey TC; Sullivan CK; Dudley MW; Schmidt CJ
    Neuropsychopharmacology; 1996 Aug; 15(2):116-24. PubMed ID: 8840347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
    Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride.
    Rabiner EA; Gunn RN; Wilkins MR; Sedman E; Grasby PM
    J Psychopharmacol; 2002 Sep; 16(3):195-9. PubMed ID: 12236624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between striatal dopamine D2/D3 receptor binding and cardiovascular activity in healthy subjects.
    Yeh TL; Yang YK; Chiu NT; Yao WJ; Yeh SJ; Wu JS; Chuang JI; Chang SH
    Am J Hypertens; 2006 Sep; 19(9):964-9. PubMed ID: 16942941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.
    Martinez D; Broft A; Foltin RW; Slifstein M; Hwang DR; Huang Y; Perez A; Frankle WG; Cooper T; Kleber HD; Fischman MW; Laruelle M
    Neuropsychopharmacology; 2004 Jun; 29(6):1190-202. PubMed ID: 15010698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats.
    Toua C; Brand L; Möller M; Emsley RA; Harvey BH
    Neuroscience; 2010 Jan; 165(2):492-9. PubMed ID: 19854242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
    Dresel S; Mager T; Rossmüller B; Meisenzahl E; Hahn K; Möller HJ; Tatsch K
    Eur J Nucl Med; 1999 Aug; 26(8):862-8. PubMed ID: 10436199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.